We help clients understand which peptides may support their goals
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of pharmacology and experimental therapeutics vol
Sosne G, et al
Researched applications In the published preclinical and clinical literature the effects of Cagrilintide are documented in the following areas: Obesity (stand-alone) , Phase 2 data (Lau 2021, 10.8 % at 4.5 mg) Obesity + Semaglutide (CagriSema) , Phase 3 REDEFINE 1 (25.3 %) T2DM + obesity , Phase 3 REDEFINE 2 Cardiovascular prevention , Phase 3 REDEFINE 3 (n ~ 7000) MASLD/MASH , exploratory in Phase 2 Type 2 diabetes (monotherapy) , preclinical data Prediabetes , exploratory plans Science & studies 4.1 Key publications Lau D.C.W., Erichsen L., Francisco A.M., et al
NAD injection Free virtual visit to discuss your goals Provider review to confirm you are a candidate Compounded NAD+ from a partner pharmacy if approved Discreet home delivery with clear instructions Simple plan, billed only when you reorder NAD for injection is a compounded product, not FDA approved for energy or aging, and is used under provider supervision
Glutathione helps regenerate vitamin C, restoring its ability to continue protecting your cells